British Scientists Develop New Treatment for Nut Allergy

British scientists have achieved significant success in combating nut allergies by applying a method of microdosing peanuts. According to Sky News, volunteers suffering from severe allergies were given minimal portions of peanut allergens over several months. Experimental data showed that two-thirds of the participants were able to tolerate small amounts of peanut flour without serious allergic reactions.

Previously, it was believed that such a method was effective only for children, whose immune systems are more flexible. However, the results of the new study disproved this view, demonstrating that adult patients can also significantly reduce their sensitivity to allergens through controlled microdosing.

In one case, a man who had suffered from a severe peanut allergy since childhood was able to completely overcome the condition. According to scientists, gradual introduction of microdoses allowed the body to adapt to the allergen without life-threatening anaphylactic reactions.

During the study, participants were prescribed microscopic doses of peanut protein, which were gradually increased. The process was conducted under strict medical supervision to minimize risks. The trials lasted several months, and eventually most participants could safely consume small amounts of a product that had previously posed a deadly threat.

Scientists emphasize that microdosing is not an instant solution and requires prolonged therapy, but it opens new perspectives for treating food allergies in adults. They note that the method could be adapted to combat allergies to other foods, including dairy, eggs, and seafood.

Specialists also stress the need for continued monitoring of patients after the active phase of therapy to ensure the results are maintained over the long term without additional intervention.

The discovery is significant for millions suffering from food allergies worldwide. According to statistics, peanut allergy remains one of the most common and dangerous food allergies, leading to thousands of hospitalizations and deaths annually.

The research team is preparing the next phase of studies to explore applying this therapy in regular medical facilities, aiming to make the treatment more accessible to a broader range of patients.

Immunology experts view the method positively, noting its potential not only to improve patients' quality of life but also to reduce the financial burden on healthcare systems. Early treatment of allergies can greatly lower the number of severe anaphylactic reactions requiring emergency intervention.

Previously, food allergy treatment was mainly limited to strict diets and emergency use of adrenaline. The new method offers an alternative strategy aimed at eliminating the root cause of allergic reactions rather than merely preventing their consequences.

British researchers stress that microdosing must be carried out strictly under medical supervision, as attempts at self-treatment can lead to serious consequences. They recommend that patients consult allergists and undergo treatment only in specialized centers.

The development reflects the broader trend in modern medicine toward personalized patient approaches. The ability to tailor dosing and therapy duration individually paves the way for more effective control of severe diseases.

Given the rising number of allergy cases worldwide, especially in developed countries, the success of British scientists could become a major milestone in fighting the disease. Wider clinical trials and the development of medical standards for this treatment are expected in the coming years.

While still experimental, the method's prospects are generating significant interest in the scientific community and among allergy treatment specialists. British scientists hope that microdosing will eventually become part of the standard therapy for food allergies.

Do you have news that could become a sensation?
Or do you want to try yourself as an editor?
On altn.news , it's possible!
Share your materials, express your opinion, and test your skills as a journalist or editor.
It’s simple:
✅ Download the app:
       
      

✅ Register on the website.
✅ Create and publish your news.
Who knows, maybe your material will become the next big headline!
Start today on altn.news.

The editorial board is not responsible for the content and accuracy of material taken, sent or obtained from other sources. The publication of such materials is for informational purposes only and does not imply automatic endorsement or approval of their content.

Now you can receive our news directly in WhatsApp! Subscribe to our channel in this popular messenger and stay up to date with all events!